Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill aims to expand HPV testing access and improve cervical cancer screening.
The problem
Some Americans lack adequate access to HPV testing services. This gap may lead to delayed cancer detection and preventable health outcomes.
The proposal
The bill seeks to close disparities in HPV testing availability. It likely expands testing access, improves screening programs, or increases funding for testing services.
The impact
Women, healthcare providers, and underserved communities gain better cancer screening access. Public health systems may need additional resources to implement expanded testing.
Expanded HPV testing helps catch cervical cancer earlier when treatment is most effective. Early detection saves lives and reduces costly emergency treatments.
Closing testing gaps helps underserved communities access preventive care. This promotes health equity across different income and geographic groups.
Preventive testing costs less than treating advanced cancer. Society saves money by catching disease early rather than treating late stages.
Wider testing coverage strengthens national cancer prevention efforts. More consistent screening across populations improves overall public health outcomes.
Expanding testing programs requires government or healthcare system funding. Costs may strain budgets or require redirecting resources from other health programs.
Without an official summary, the bill's specific approach and requirements are unknown. This makes it difficult to assess full consequences or workability.
Rapid expansion of testing may overload clinics and labs with new patients. Healthcare providers may struggle to meet increased demand without more staff.
Expanded testing increases positive results requiring follow-up care. Some results may be false alarms, causing patient anxiety and unnecessary procedures.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.